Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

NAYA

NAYA Biosciences

Dec 11 • 04:00PM ET

0.8286

Dollar change +0.0485
Percentage change 6.21	%

Healthcare • Medical Devices • USA • NASD

Peers: LLY MRK ABBV PFE BMY VRTX REGN GILD AMGN BIIB

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.54	Insider Own	0.50%	Shs Outstand	4.94M	Perf Week	-9.95%
Market Cap	4.09M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	4.91M	Perf Month	-4.76%
Income	-7.08M	PEG	-	EPS next Q	-	Inst Own	5.55%	Short Float	1.52%	Perf Quarter	18.36%
Sales	5.77M	P/S	0.71	EPS this Y	-	Inst Trans	-	Short Ratio	0.07	Perf Half Y	9.02%
Book/sh	-1.59	P/B	-	EPS next Y	-	ROA	-57.44%	Short Interest	0.07M	Perf Year	-40.39%
Cash/sh	0.19	P/C	4.35	EPS next 5Y	-	ROE	-14358.50%	52W Range	0.63 - 3.50	Perf YTD	-38.63%
Dividend Est.	-	P/FCF	-	EPS past 5Y	17.42%	ROI	-140.49%	52W High	-76.33%	Beta	1.54
Dividend TTM	-	Quick Ratio	0.27	Sales past 5Y	131.54%	Gross Margin	34.15%	52W Low	31.29%	ATR (14)	0.09
Dividend Ex-Date	-	Current Ratio	0.30	EPS Y/Y TTM	84.00%	Oper. Margin	-90.89%	RSI (14)	46.32	Volatility	9.53% 10.17%
Employees	30	Debt/Eq	3.96	Sales Y/Y TTM	390.03%	Profit Margin	-122.80%	Recom	3.00	Target Price	2.00
Option/Short	No / Yes	LT Debt/Eq	2.71	EPS Q/Q	79.67%	Payout	-	Rel Volume	0.07	Prev Close	0.78
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	481.38%	Earnings	Aug 14 BMO	Avg Volume	1.13M	Price	0.83
SMA20	-5.52%	SMA50	-2.03%	SMA200	-7.04%	Trades		Volume	79,109	Change	6.21%

Oct-31-24 09:00AM	NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC) (GlobeNewswire)
Oct-24-24 09:00AM	NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma (GlobeNewswire)
Oct-21-24 09:00AM	INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences (GlobeNewswire)
Oct-14-24 09:18AM	INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) (GlobeNewswire) +89.31%
Aug-14-24 09:00AM	INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA (GlobeNewswire)
09:53PM	Loading…
May-15-24 09:53PM	INVO Stock Earnings: INVO Bioscience Reported Results for Q1 2024 (InvestorPlace) -6.54%
04:15PM	INVO Reports Record First Quarter 2024 Financial Results (GlobeNewswire)
May-14-24 07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -8.20%
Apr-17-24 08:16AM	Why Is Invo Bioscience (INVO) Stock Up 85% Today? (InvestorPlace) +139.47%
Apr-16-24 09:53PM	INVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023 (InvestorPlace)
04:59PM	INVO Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Jan-23-24 08:00AM	NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON) (GlobeNewswire) +6.80%
Jan-17-24 08:00AM	INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors (GlobeNewswire) +12.38%
Dec-11-23 08:00AM	NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK Bispecific Antibody in the American Society of Hematology's Blood Journal (PR Newswire)
Dec-06-23 09:00AM	NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies (PR Newswire)
09:00AM	Loading…
Nov-28-23 09:00AM	INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement (PR Newswire) -12.02%
Nov-13-23 04:01PM	INVO Reports Record Third Quarter 2023 Financial Results (PR Newswire) +22.90% +34.16%
08:15AM	BestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Merger (News Direct)
Nov-10-23 09:00AM	NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger (PR Newswire) +90.68%
Nov-09-23 04:40PM	INVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrants (PR Newswire) -12.13%
Oct-27-23 09:00AM	Free Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023 (PR Newswire) -5.80%
Oct-24-23 10:08AM	Moore Kuehn Encourages INVO, ESMT, HES, and TGH Investors to Contact Law Firm (GlobeNewswire) -30.19%
08:45AM	Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments (PR Newswire)
Oct-23-23 01:40PM	Why Is INVO Bioscience (INVO) Stock Up 325% Today? (InvestorPlace) +292.59%
07:30AM	INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company (PR Newswire)
Oct-11-23 09:00AM	INVO to Participate in the Lytham Partners Fall 2023 Investor Conference (PR Newswire) -10.16%
Sep-29-23 04:05PM	INVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF SHAREHOLDERS (PR Newswire) -7.59%
Sep-28-23 12:30PM	INVO Reminds Shareholders to Cast Their Vote for Upcoming Special Meeting of Shareholders to be held on Friday, September 29, 2023 at 12:00 p.m. ET (PR Newswire)
Aug-14-23 04:05PM	INVO Reports Second Quarter 2023 Financial Results (PR Newswire) -15.68%
Aug-11-23 08:00AM	INVO Closes Acquisition of Wisconsin Fertility Institute (PR Newswire) -6.82%
04:15PM	Loading…
Aug-09-23 04:15PM	INVO to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023 (PR Newswire) -5.38%
Aug-08-23 01:55PM	INVO Bioscience Announces Closing of $4.5 Million Public Offering (PR Newswire)
Aug-04-23 09:00AM	INVO Bioscience Announces Pricing of $4.5 Million Public Offering (PR Newswire) -36.71%
Aug-03-23 08:00AM	INVO Sets Revised Closing Date of Wisconsin Fertility Institute Acquisition and Announces Key Operational Trends to Drive Shareholder Value (PR Newswire) -20.20%
Jul-27-23 09:26AM	INVO Announces a 1:20 Reverse Stock Split Effective Pre-Market Opening on July 28, 2023 (PR Newswire) +22.53%
Jun-27-23 09:00AM	INVO Receives 510(k) FDA Clearance for Expanded Use of the INVOcell Device (PR Newswire) -8.75%
May-15-23 04:05PM	INVO Reports First Quarter 2023 Financial Results (PR Newswire)
May-08-23 04:15PM	INVO Bioscience to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (PR Newswire) -8.25%
Apr-17-23 04:05PM	INVO Reports Fourth Quarter and Full Year 2022 Financial Results (PR Newswire) +8.30% -11.53%
Apr-11-23 05:30PM	INVO Bioscience to Report Fourth Quarter and Fiscal Year 2022 Financial Results on Monday, April 17, 2023 (PR Newswire) -6.49%
Apr-05-23 09:00AM	INVO Congratulates Wisconsin Fertility Institute on Being Named One of America's Best Fertility Clinics by Newsweek (PR Newswire)
Mar-30-23 05:25PM	INVO Provides Preliminary Update on FY2022 Financial Results (PR Newswire) +6.45%
Mar-27-23 05:06PM	INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering (PR Newswire)
Mar-24-23 08:00AM	INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market (PR Newswire) -8.70%
Mar-20-23 09:00AM	INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute (PR Newswire) +14.42%
Jan-05-23 09:00AM	INVO Bioscience Enters Distribution Agreement for Taiwan (PR Newswire) +6.96%
Jan-03-23 09:00AM	INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center (PR Newswire)
Nov-30-22 09:30AM	First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology (PR Newswire)
Nov-14-22 04:05PM	INVO Bioscience Reports Third Quarter 2022 Financial Results (PR Newswire) +5.08%
Nov-10-22 04:15PM	INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 (PR Newswire) +11.00%
Nov-01-22 09:00AM	INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Oct-21-22 09:00AM	INVOcell Review Published in Current Opinion in Obstetrics and Gynecology (PR Newswire)
Oct-17-22 09:00AM	INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Sep-22-22 09:00AM	Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly (PR Newswire) -11.57%
Aug-25-22 09:00AM	INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz (PR Newswire)
Aug-15-22 04:05PM	INVO Bioscience Reports Second Quarter 2022 Financial Results (PR Newswire) +5.61% -7.96%
Aug-04-22 04:15PM	INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 (PR Newswire)
Jul-07-22 08:00AM	INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment (PR Newswire) +7.31%
May-16-22 04:15PM	INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China (PR Newswire) +10.25%
04:05PM	INVO Bioscience Reports First Quarter 2022 Financial Results (PR Newswire)
May-09-22 04:30PM	INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 (PR Newswire) -18.50%
Apr-28-22 09:00AM	INVO Celebrates National Infertility Awareness Week at the INVO Center in Atlanta, Georgia (PR Newswire)
Apr-14-22 09:00AM	INVO Selects Kansas City as additional INVO Center Location (PR Newswire) -8.74%
Apr-04-22 09:00AM	INVO Bioscience to Participate in the Lytham Partners Spring 2022 Investor Conference (PR Newswire) +7.38%
Mar-31-22 04:05PM	INVO Bioscience Reports 2021 Financial Results (PR Newswire) -6.06%
Mar-24-22 04:15PM	INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022 (PR Newswire)
09:00AM	INVO Bioscience to Exhibit at the 2022 Pacific Coast Reproductive Society (PCRS) Annual Meeting (PR Newswire)
Mar-22-22 09:00AM	INVO Bioscience to Participate in Roundtable Discussion at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest (PR Newswire)
Mar-10-22 09:00AM	New Birmingham INVO Center Offers Families an Affordable Advanced Fertility Treatment Solution to Help Combat Rising Costs (PR Newswire)
Feb-16-22 09:00AM	INVO to Launch Additional INVO Center in Tampa, Florida (PR Newswire)
Feb-09-22 08:00AM	INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment 'INVO Centers' (ACCESSWIRE Test RSS)
Feb-03-22 09:00AM	INVO Bioscience Expands U.S. Commercialization Efforts (PR Newswire) +5.01%
Dec-16-21 09:00AM	INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization (PR Newswire)
Dec-10-21 02:05PM	INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference (PR Newswire)
Dec-01-21 09:00AM	INVO Bioscience Obtains Regulatory Approval to Commercialize INVOcell In Thailand (PR Newswire)
Nov-15-21 04:05PM	INVO Bioscience Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update (PR Newswire)
Nov-09-21 04:15PM	INVO Bioscience to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021 (PR Newswire)
Nov-08-21 04:15PM	INVO Bioscience Regains Full U.S. Commercialization Rights (PR Newswire)
03:00PM	Will Invo BioScience Inc. (INVO) Report Negative Q3 Earnings? What You Should Know (Zacks)
Oct-20-21 09:00AM	INVO Bioscience Announces Four Individual Poster Abstracts Discussing the Benefits of INVOcell Presented at the 2021 American Society for Reproductive Medicine (ASRM) Congress & Expo (PR Newswire)
Oct-14-21 09:00AM	INVO Bioscience Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021 (PR Newswire) +11.33%
Oct-01-21 09:29AM	INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (PR Newswire)
Sep-09-21 08:00AM	INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada (PR Newswire)
Sep-07-21 09:00AM	INVO Bioscience Announces Official Opening of "Bloom Fertility, an INVO Center" in Atlanta (PR Newswire)
Sep-03-21 09:00AM	Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference (PR Newswire)
Aug-16-21 04:05PM	INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update (PR Newswire) -6.59%
Aug-05-21 04:15PM	INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021 (PR Newswire)
03:01PM	Invo BioScience Inc. (INVO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Aug-02-21 04:05PM	INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama (PR Newswire)
Jul-14-21 08:30AM	INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration (PR Newswire)
Jun-30-21 09:30AM	INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta (PR Newswire)
Jun-15-21 09:00AM	INVO Bioscience Appoints Andrea Goren as Chief Financial Officer (PR Newswire) -11.50%
May-17-21 04:05PM	INVO Bioscience Reports First Quarter 2021 Financial and Operating Results and Provides Business Update (PR Newswire)
02:45PM	INVO BioScience, Inc. to Host Earnings Call (ACCESSWIRE)
May-11-21 04:15PM	INVO Bioscience to Report First Quarter 2021 Financial Results on Monday, May 17, 2021 (PR Newswire) +6.20%
May-10-21 08:30AM	INVO Bioscience Appoints Meryle Lynn Chamberlain to Lead Marketing for Global Brand Expansion (PR Newswire)
Apr-26-21 04:05PM	INVO Bioscience Announces Appointment of Rebecca Messina to the Board of Directors (PR Newswire)
Apr-22-21 11:02AM	INVO Bioscience Joins in Supporting RESOLVE: The National Infertility Association During its National Infertility Awareness Week (NIAW) (PR Newswire) +6.93%
Apr-19-21 09:00AM	INVO Bioscience Signs Partnership Agreement with Lyfe Medical to Establish INVOcell Clinic in Northern California (PR Newswire)
Apr-12-21 03:00PM	INVO Bioscience to Present at Tribe Public Event on April 13, 2021 (PR Newswire)

NAYA Biosciences, Inc. operates a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on October 14, 2024 and is headquartered in Sarasota, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NAYA

NAYA Biosciences

Upgrade your FINVIZ experience